Long-term topiramate treatment of psychotropic drug-induced weight gain: a retrospective chart review

General Hospital Psychiatry

Volumn 29, Issue 5, 2007, Pages 446-449

  Khazaal, Yasser ^a   Chatton, Anne ^b   Rusca, Manon ^a   Preisig, Martin ^a   Zullino, Daniele ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Antipsychotic drugs; Binge eating; Bipolar disorders; Lithium; Obesity; Psychotic disorders; Substance abuse; Topiramate; Valproate; Weight

Indexed keywords

AMISULPRIDE; CLOZAPINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID;

ARTICLE; BINGE EATING DISORDER; BIPOLAR DISORDER; BODY MASS; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEADACHE; HUMAN; LONG TERM CARE; MENTAL DISEASE; META ANALYSIS; OBESITY; PARESTHESIA; PERSONALITY DISORDER; PSYCHOMOTOR RETARDATION; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SIDE EFFECT; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; ANTI-OBESITY AGENTS; FEMALE; FRUCTOSE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SWITZERLAND; WEIGHT GAIN;

EID: 34548629008     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2007.05.001     Document Type: Article

References (28)

1. Nasrallah H. A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 28 Suppl 1 (2003) 83-96
2. Green A.I., Patel J.K., Goisman R.M., et al. Weight gain from novel antipsychotic drugs: need for action. Gen Hosp Psychiatry 22 4 (2000) 224-235
3. Chengappa K.N., Chalasani L., Brar J.S., et al. Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review. Clin Ther 24 10 (2002) 1576-1584
4. Brar J.S., Ganguli R., Pandina G., et al. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 66 2 (2005) 205-212
5. Khazaal Y., Fresard E., Rabia S., et al. Cognitive behavioural therapy for weight gain associated with antipsychotic drugs. Schizophr Res 91 1-3 (2007) 169-177
6. Werneke U., Taylor D., and Sanders T.A. Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int Clin Psychopharmacol 17 4 (2002) 145-160
7. White H.S., Brown S.D., Woodhead J.H., et al. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 28 3 (1997) 167-179
8. Bray G.A., Hollander P., Klein S., et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 11 6 (2003) 722-733
9. Wilding J., Van Gaal L., Rissanen A., et al. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects. Int J Obes Relat Metab Disord 28 11 (2004) 1399-1410
10. Astrup A., Caterson I., Zelissen P., et al. Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. Obes Res 12 10 (2004) 1658-1669
11. Tremblay A., Chaput J.P., Berube-Parent S., et al. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. Eur J Clin Pharmacol 63 2 (2007) 123-134
12. Li Z., Maglione M., Tu W., et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 142 7 (2005) 532-546
13. Kim J.H., Yim S.J., and Nam J.H. A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia. Schizophr Res 82 1 (2006) 115-117
14. Gupta S., Masand P.S., Frank B.L., et al. Topiramate in bipolar and schizoaffective disorders: weight loss and efficacy. Prim Care companion J Clin Psychiat 2 3 (2000) 96-100
15. Erfurth A., and Kuhn G. Topiramate monotherapy in the maintenance treatment of bipolar I disorder: effects on mood, weight and serum lipids. Neuropsychobiology 42 Suppl 1 (2000) 50-51
16. Lin Y.H., Liu C.Y., and Hsiao M.C. Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate. Psychiatry Clin Neurosci 59 5 (2005) 613-615
17. Nickel M.K., Nickel C., Muehlbacher M., et al. Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study. J Clin Psychopharmacol 25 3 (2005) 211-217
18. Ko Y.H., Joe S.H., Jung I.K., et al. Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain. Clin Neuropharmacol 28 4 (2005) 169-175
19. Kirov G., and Tredget J. Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series. BMC Psychiatry 5 1 (2005) 19
20. Vieta E., Goikolea J.M., Olivares J.M., et al. 1-Year follow-up of patients treated with risperidone and topiramate for a manic episode. J Clin Psychiatry 64 7 (2003) 834-839
21. McElroy S.L., Shapira N.A., Arnold L.M., et al. Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry 65 11 (2004) 1463-1469
22. McElroy S.L., Arnold L.M., Shapira N.A., et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 160 2 (2003) 255-261
23. McElroy S.L., Hudson J.I., Capece J.A., et al. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry 61 9 (2007) 1039-1048
24. Biton V., Edwards K.R., Montouris G.D., et al. Topiramate titration and tolerability. Ann Pharmacother 35 2 (2001) 173-179
25. Fedoroff I., Polivy J., and Herman C.P. The specificity of restrained versus unrestrained eaters' responses to food cues: general desire to eat or craving for the cued food?. Appetite 41 1 (2003) 7-13
26. Zullino D.F., Krenz S., Zimmerman G., et al. Topiramate in opiate withdrawal - comparison with clonidine and with carbamazepine/mianserin. Subst Abus 25 4 (2005) 27-33
27. Fallon A.E., and Rozin P. Sex differences in perceptions of desirable body shape. J Abnorm Psychol 94 1 (1985) 102-105
28. Khazaal Y., Fresard E., Zimmermann G., et al. Eating and weight related cognitions in people with schizophrenia: a case control study. Clin Pract Epidemol Ment Health 2 (2006) 29